跳至主要内容
临床试验/IRCT20091012002581N7
IRCT20091012002581N7招募中3 期

Comparison between fluocinolone plus tacrolimus and fluocinolone plus NBUVB in the treatment of localized morphea

Tabriz University of Medical Sciences0 个研究点目标入组 20 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • The disease is in its active phase
  • Patients have not received any treatment in the past 6 weeks
  • Existence of at least one morphea plaque with a total area of cm2 10
  • Lack of use of immunosuppressants, penicillamine, interferon gamma, or phototherapy in the last three months

排除标准

  • Systemic sclerosis or pseudosclerosis
  • Existence of a history of side effects in previous use of tacrolimus (hypersensitivity, intolerance)
  • Contraceptive radiation therapy
  • Pregnant women or those who are planning to become pregnant during treatment
  • Breastfeeding women
  • Infectious active lesion at the site of morphea plaque
  • Recent vaccinations (28 days before the start of the study)
  • Borrelia burgdorferi infection (serological diagnosis)

研究者

相似试验